The GN02 study is a new clinical research study from Eli Lilly and Company. GN02 is a weight management study. It will test if an investigational medicine can safely reduce body weight in people with type 2 diabetes and obesity or overweight when compared to placebo.
Investigational medicine means it is still being tested in clinical research studies. A placebo looks the same as an investigational medicine but does not have any real medicine in it.
Can I join this study?
Yes, you may be able to join the study if you:
- are aged 18 to 75 years
- cannot become pregnant
- have type 2 diabetes that you treated with diet and exercise alone or with a stable dose of metformin.
- have not taken insulin in the past year, and
- have a BMI of 27kg/m 2 or more
BMI stands for body mass index. It is a number that compares a person’s weight to their height. It can be used to tell if a person may be at risk of some health conditions.
For more information: 786-772-0510
